🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study, a pilot randomized controlled trial, single-blind (outcome asse...
Status
Completed
Location
Faculty of Medicine, Prince of Songkla University
Start Date
2024-03-01
Trial ID
NCT06831786
Treatments Being Tested
A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Status
Completed
Location
US135
Start Date
2019-10-14
Trial ID
NCT04120194
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-29
Trial ID
NCT02369341
Treatments Being Tested
This study compares the immunogenity and safety of quadrivalent inactivated...
Status
Unknown
Location
Hospital Puerto Montt
Start Date
2022-07-14
Trial ID
NCT05494047
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-01
Trial ID
NCT01439360
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-01
Trial ID
NCT02242643
Treatments Being Tested
The purpose of this trial is to demonstrate the acceptable safety profile a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-18
Trial ID
NCT02207413
This study is designed to test the immunogenicity and safety of an investig...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-01
Trial ID
NCT01198756
This is a randomized, observer-blinded, Phase 2 study evaluating the safety...
Status
Completed
Location
Paratus Clinical Research - Canberra
Start Date
2022-12-30
Trial ID
NCT05519839
Primary Objective: To demonstrate that high-dose quadrivalent influenza va...
Status
Completed
Location
Investigational Site Number 0560001
Start Date
2019-10-28
Trial ID
NCT04024228
Treatments Being Tested